Related Experiment Videos
[Circulating immune complexes and immunologic reactivity in breast cancer]
Eksperimental'Naia Onkologiia
|January 1, 1984
Summary
Elevated immune complexes in breast cancer patients correlate with advanced tumor stages and reduced T-lymphocyte function. These findings suggest immune complexes may act as a specific blocking factor in oncological disease progression.
Area of Science:
- Oncology
- Immunology
Context:
- Breast cancer patients
- Comparative study
Purpose:
- Investigate the role of immune complexes in breast cancer
- Assess the relationship between immune complexes and disease stage
- Evaluate the impact of immune complexes on T-lymphocyte function
Summary:
- 117 breast cancer patients were studied for immune complexes, T-lymphocytes, serum immunoglobulins, and lymphocyte blast transformation.
- Elevated immune complexes were observed, correlating with increased tumor mass and advanced stages (III-IV).
- In advanced stages, high immune complex levels were linked to T-lymphocyte depletion, reduced response to PHA, and increased IgM concentration.
Impact:
- Suggests immune complexes may function as specific blocking factors in oncological disease.
- Highlights potential biomarkers for breast cancer progression.
- Informs future research on immunomodulatory therapies for cancer.